MetaCap

Helus Pharma Statistics

NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.11-0.67 (-9.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Helus Pharma by the numbers

Helus Pharma has a market capitalization of $487.7 million based on 79.81M shares outstanding. With trailing EPS of $-4.25, Helus Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 42.6% below its 50-day average and 21.7% below its 200-day average.

Average daily trading volume is 1.83M shares, or about $11.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HELP valuation vs. peer median

HELP compared with the median of 8 peer companies
MetricHELPPeer medianDifference
Market cap$487.68M$466.59M+5%
Avg. volume1.83M250.46K+631%

Peer median across 8 companies: WVE, EVO, MNPR, RZLT, ALMS, BLSM, GYRE, NGNE.

Valuation

Price and trading

Previous close
6.78
Open
6.63
Day range
6.05 – 6.73
52-week range
3.76 – 15.15
52-week change
+9.30%
Beta
—
Volume
2.50M

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
487.68M
Forward Pe
-2.48
Eps
-4.25
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
15.15
Week52 Low
3.76
Avg Volume
1.83M
Shares Outstanding
79.81M
Ma50
10.65
Ma200
7.80
Earnings Date
Nov 16, 2026
Pct From52w High
-59.67%
Pct From52w Low
62.50%

Related